Drugs 9.2 Recreational drugs 9.3 Complementary medicine 8. Other Treatments . There are trials of new drugs being carried out by various pharmaceutical companies, hospitals and medical research teams and you may wish to consider joining one of these. Most of these studies are double blind. I.e. you will not know if you are taking the new drug or a placebo.
Some studies also combine interferon with the new drug.
The report notes that significant antiviral effect was observed in interferon unresponsive and refractory patients. These results may have an enormous impact in the treatment of chronic hepatitis patients, if Famvir's potential use in long-term therapy is proven. However, further clinical trials over a longer period will answer criticism regarding Famvir as a long-term or maintenance therapy. A small pilot study of this therapy demonstrated an antiviral effect, as documented by a fall in serum HBV DNA, and may have promise particularly in patients with leukopenia, who would otherwise benefit from interferon therapy Lamivudine or 3TC A preliminary trial of lamivudine for chronic hepatitis B infection , Dienstag, J. L., Perrillo, R. P., Schiff, E. R., Bartholomew, M., Vicary, C., and Rubin, New England Journal of Medicine, 1995. Serum hepatitis Be antigen disappeared in four patients.